Skip to Main Content

Paper Details

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7.
bioRxiv
193
2021
B.1, B.1.351, COVID-, COVID-19, E484K, N, NTD mAbs, SARS, SARS-, SARS-CoV, SARS-CoV-2, convalescent plasma, mAbs, monoclonal, vaccine constructs
Author NameAffiliation
Baoshan ZhangAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons
Peter D KwongVaccine Research Center, National Institutes of Health
John R MascolaVaccine Research Center, National Institutes of Health
Lawrence ShapiroRegeneron Pharmaceuticals, Inc.
Lawrence ShapiroRegeneron Pharmaceuticals, Inc.
  • 1 - 5

Datasets

Release 1.2